Cellebrite/CLBT

$10.55

-3.12%
-
1D1W1MYTD1YMAX

About Cellebrite

Cellebrite DI Ltd is an Israel-based software developer. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Platform enables users to collect, view, analyse and manage digital data throughout the entire investigation cycle. The Company's platform improves the investigation process for public defenders, police departments, state departments, armed services, legal and corporate security; this leads to an accelerated speed of investigations and increased crime clearance rates.

Ticker

CLBT

Sector

Technology

Trading on

NASDAQ

Industry

Software & Programming

CEO

Yossi Carmil

Employees

1,008

Headquarters

Petah tikva, Israel

Cellebrite Metrics

BasicAdvanced
$2.24B
Market cap
-
P/E ratio
-$0.43
EPS
1.53
Beta
-
Dividend rate
$2.24B
1.52904
$12.50
$5.22
984.16K
1.663
1.624
0.31%
-17.33%
-150.08%
-34.18%
6.889
64.796
23.792
20.12%
-171.18%
18.59%

What the Analysts think about Cellebrite

Analyst Ratings

Majority rating from 7 analysts.
Buy

Price Targets

Average projection from 5 analysts.
29.86% upside
High $15.00
Low $13.00
$10.55
Current price
$13.70
Average price target

Cellebrite Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-15.69% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$93M
10.58%
Net income
$-14.6M
-324.62%
Profit margin
-15.69%
-303.24%

Cellebrite Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 89.66%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.04
$0.05
$0.10
$0.11
-
Expected
$0.02
$0.02
$0.05
$0.06
$0.06
Surprise
77.78%
114.29%
118.95%
89.66%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Cellebrite stock?

Cellebrite (CLBT) has a market cap of $2.24B as of April 13, 2024.

What is the P/E ratio for Cellebrite stock?

The price to earnings (P/E) ratio for Cellebrite (CLBT) stock is 0 as of April 13, 2024.

Does Cellebrite stock pay dividends?

No, Cellebrite (CLBT) stock does not pay dividends to its shareholders as of April 13, 2024.

When is the next Cellebrite dividend payment date?

Cellebrite (CLBT) stock does not pay dividends to its shareholders.

What is the beta indicator for Cellebrite?

Cellebrite (CLBT) has a beta rating of 1.53. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Cellebrite stock price target?

The target price for Cellebrite (CLBT) stock is $13.7, which is 29.86% above the current price of $10.55. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Cellebrite stock

Buy or sell Cellebrite stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing